Palladium(II) complexes with R(2)edda derived ligands. Part IV. O,O '-dialkyl esters of (S,S)-ethylenediamine-N,N '-di-2-(4-methyl)-pentanoic acid dihydrochloride and their palladium(II) complexes: Synthesis, characterization and in vitro antitumoral acti
Само за регистроване кориснике
2010
Аутори
Vujić, Jelena M.Cvijović, Milica
Kaluđerović, Goran N.
Milovanović, Marija
Zmejkovski, Bojana B.
Volarevic, Vladislav
Arsenijević, Nebojša
Sabo, Tibor
Trifunović, Srećko R.
Чланак у часопису (Објављена верзија)
Метаподаци
Приказ свих података о документуАпстракт
Four novel bidentate N,N'-ligand precursors, including O,O'-dialkyl esters (alkyl = ethyl, n-propyl, n-butyl and n-pentyl), L1 center dot 2HCl-L4 center dot 2HCl, of (S,S)-ethylenediamine-N,N'-di-2-(4-methyl)-pentanoic acid dihydrochloride [(S,S)-H(4)eddl]Cl-2 and the corresponding palladium(II) complexes 1-4, were prepared and characterized by IR, H-1 NMR and C-13 NMR spectroscopy and elemental analysis. In vitro cytotoxicity of all compounds was determined against chronic lymphocytic leukemia cells (CLL). The compounds were found to exhibit higher antitumoral activity than cisplatin. The most active compound 2, [PdCl2{(S,S)-nPr(2)eddl}], was found to be 13.6 times more active than cisplatin on CLL cells. (C) 2010 Elsevier Masson SAS. All rights reserved.
Кључне речи:
Palladium(II) complexes / Edda-type ligands / Antitumoral activity / Chronic lymphocytic leukemia cellsИзвор:
European Journal of Medicinal Chemistry, 2010, 45, 9, 3601-3606Издавач:
- Elsevier France-Editions Scientifiques Medicales Elsevier, Paris
Финансирање / пројекти:
- Синтеза, карактеризација и активност органских и координационих једињења и њихова примена у (био)нанотехнологији (RS-142010)
- Структура нових комплекса јона прелазних метала и механизам њихових реакција са биолошки значајним лигандима (RS-142008)
- Имнорегулаторне интеракције у туморским и аутоимунским феноменима (RS-145065)
- EC
DOI: 10.1016/j.ejmech.2010.05.005
ISSN: 0223-5234
PubMed: 20570025
WoS: 000281568600011
Scopus: 2-s2.0-77955558644
Колекције
Институција/група
Hemijski fakultet / Faculty of ChemistryTY - JOUR AU - Vujić, Jelena M. AU - Cvijović, Milica AU - Kaluđerović, Goran N. AU - Milovanović, Marija AU - Zmejkovski, Bojana B. AU - Volarevic, Vladislav AU - Arsenijević, Nebojša AU - Sabo, Tibor AU - Trifunović, Srećko R. PY - 2010 UR - https://cherry.chem.bg.ac.rs/handle/123456789/1112 AB - Four novel bidentate N,N'-ligand precursors, including O,O'-dialkyl esters (alkyl = ethyl, n-propyl, n-butyl and n-pentyl), L1 center dot 2HCl-L4 center dot 2HCl, of (S,S)-ethylenediamine-N,N'-di-2-(4-methyl)-pentanoic acid dihydrochloride [(S,S)-H(4)eddl]Cl-2 and the corresponding palladium(II) complexes 1-4, were prepared and characterized by IR, H-1 NMR and C-13 NMR spectroscopy and elemental analysis. In vitro cytotoxicity of all compounds was determined against chronic lymphocytic leukemia cells (CLL). The compounds were found to exhibit higher antitumoral activity than cisplatin. The most active compound 2, [PdCl2{(S,S)-nPr(2)eddl}], was found to be 13.6 times more active than cisplatin on CLL cells. (C) 2010 Elsevier Masson SAS. All rights reserved. PB - Elsevier France-Editions Scientifiques Medicales Elsevier, Paris T2 - European Journal of Medicinal Chemistry T1 - Palladium(II) complexes with R(2)edda derived ligands. Part IV. O,O '-dialkyl esters of (S,S)-ethylenediamine-N,N '-di-2-(4-methyl)-pentanoic acid dihydrochloride and their palladium(II) complexes: Synthesis, characterization and in vitro antitumoral acti VL - 45 IS - 9 SP - 3601 EP - 3606 DO - 10.1016/j.ejmech.2010.05.005 ER -
@article{ author = "Vujić, Jelena M. and Cvijović, Milica and Kaluđerović, Goran N. and Milovanović, Marija and Zmejkovski, Bojana B. and Volarevic, Vladislav and Arsenijević, Nebojša and Sabo, Tibor and Trifunović, Srećko R.", year = "2010", abstract = "Four novel bidentate N,N'-ligand precursors, including O,O'-dialkyl esters (alkyl = ethyl, n-propyl, n-butyl and n-pentyl), L1 center dot 2HCl-L4 center dot 2HCl, of (S,S)-ethylenediamine-N,N'-di-2-(4-methyl)-pentanoic acid dihydrochloride [(S,S)-H(4)eddl]Cl-2 and the corresponding palladium(II) complexes 1-4, were prepared and characterized by IR, H-1 NMR and C-13 NMR spectroscopy and elemental analysis. In vitro cytotoxicity of all compounds was determined against chronic lymphocytic leukemia cells (CLL). The compounds were found to exhibit higher antitumoral activity than cisplatin. The most active compound 2, [PdCl2{(S,S)-nPr(2)eddl}], was found to be 13.6 times more active than cisplatin on CLL cells. (C) 2010 Elsevier Masson SAS. All rights reserved.", publisher = "Elsevier France-Editions Scientifiques Medicales Elsevier, Paris", journal = "European Journal of Medicinal Chemistry", title = "Palladium(II) complexes with R(2)edda derived ligands. Part IV. O,O '-dialkyl esters of (S,S)-ethylenediamine-N,N '-di-2-(4-methyl)-pentanoic acid dihydrochloride and their palladium(II) complexes: Synthesis, characterization and in vitro antitumoral acti", volume = "45", number = "9", pages = "3601-3606", doi = "10.1016/j.ejmech.2010.05.005" }
Vujić, J. M., Cvijović, M., Kaluđerović, G. N., Milovanović, M., Zmejkovski, B. B., Volarevic, V., Arsenijević, N., Sabo, T.,& Trifunović, S. R.. (2010). Palladium(II) complexes with R(2)edda derived ligands. Part IV. O,O '-dialkyl esters of (S,S)-ethylenediamine-N,N '-di-2-(4-methyl)-pentanoic acid dihydrochloride and their palladium(II) complexes: Synthesis, characterization and in vitro antitumoral acti. in European Journal of Medicinal Chemistry Elsevier France-Editions Scientifiques Medicales Elsevier, Paris., 45(9), 3601-3606. https://doi.org/10.1016/j.ejmech.2010.05.005
Vujić JM, Cvijović M, Kaluđerović GN, Milovanović M, Zmejkovski BB, Volarevic V, Arsenijević N, Sabo T, Trifunović SR. Palladium(II) complexes with R(2)edda derived ligands. Part IV. O,O '-dialkyl esters of (S,S)-ethylenediamine-N,N '-di-2-(4-methyl)-pentanoic acid dihydrochloride and their palladium(II) complexes: Synthesis, characterization and in vitro antitumoral acti. in European Journal of Medicinal Chemistry. 2010;45(9):3601-3606. doi:10.1016/j.ejmech.2010.05.005 .
Vujić, Jelena M., Cvijović, Milica, Kaluđerović, Goran N., Milovanović, Marija, Zmejkovski, Bojana B., Volarevic, Vladislav, Arsenijević, Nebojša, Sabo, Tibor, Trifunović, Srećko R., "Palladium(II) complexes with R(2)edda derived ligands. Part IV. O,O '-dialkyl esters of (S,S)-ethylenediamine-N,N '-di-2-(4-methyl)-pentanoic acid dihydrochloride and their palladium(II) complexes: Synthesis, characterization and in vitro antitumoral acti" in European Journal of Medicinal Chemistry, 45, no. 9 (2010):3601-3606, https://doi.org/10.1016/j.ejmech.2010.05.005 . .